Related references
Note: Only part of the references are listed.Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients
Vincent J. Lempers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Efficacy and Tolerability of Micafungin Monotherapy for Candidemia and Deep-Seated Candidiasis in Adults with Cancer
Dimitrios Farmakiotis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
Jose Vazquez et al.
BMC INFECTIOUS DISEASES (2014)
A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
S. Kohno et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2013)
How to select an antifungal agent in critically ill patients
George Dimopoulos et al.
JOURNAL OF CRITICAL CARE (2013)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
European expert opinion on the management of invasive candidiasis in adults
B. J. Kullberg et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett et al.
CRITICAL CARE MEDICINE (2011)
Diagnosis of invasive candidiasis in the ICU
Philippe Eggimann et al.
ANNALS OF INTENSIVE CARE (2011)
Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
John R. Prowle et al.
CRITICAL CARE (2011)
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
Daniel H. Kett et al.
CRITICAL CARE (2011)
Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection
Jiun-Ling Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Evaluation of Caspofungin or Micafungin as Empiric Antifungal Therapy in Adult Patients With Persistent Febrile Neutropenia: A Retrospective, Observational, Sequential Cohort Analysis
David W. Kubiak et al.
CLINICAL THERAPEUTICS (2010)
Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome?
Oscar Marchetti et al.
CURRENT OPINION IN CRITICAL CARE (2010)
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
Olivier Leroy et al.
CRITICAL CARE MEDICINE (2009)
Usefulness of the Candida score for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
Cristobal Leon et al.
CRITICAL CARE MEDICINE (2009)
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment
Benoit P. Guery et al.
INTENSIVE CARE MEDICINE (2009)
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Benoit P. Guery et al.
INTENSIVE CARE MEDICINE (2009)
'Liver function tests' on the intensive care unit: a prospective, observational study
S. J. Thomson et al.
INTENSIVE CARE MEDICINE (2009)
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections:: Differences in risk factors and outcome
George Dimopoulos et al.
ANESTHESIA AND ANALGESIA (2008)
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
Yasushi Hiramatsu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
